期刊的影响因子--文章列表

期刊文章列表
Zhiliang Wang¹，Wen Cheng²，Zheng Zhao¹，Zheng Wang³，Chuanbao Zhang³，Guanzhang Li¹，Anhua Wu²，Tao Jiang^1,3（Department of Neurosurgery；Department of Neurosurgery；Department of Neurosurgery）.Comparative profiling of immune genes improves the prognoses of lower grade gliomas[J].癌症生物学与医学(英文版),2022,第4期 Yu Mei¹，Tienan Feng²，Min Yan¹，Zhenggang Zhu¹，Zhenglun Zhu¹（Department of General Surgery；Clinical Research Institute）.Is adjuvant chemotherapy necessary for early gastric cancer?[J].癌症生物学与医学(英文版),2022,第4期 Xiaodong Zhang，Yufei Wang²，Guang Yang（Department of Gastrointestinal Cancer Biology；Department of Cancer Research）.Research progress in hepatitis B virus covalently closed circular DNA[J].癌症生物学与医学(英文版),2022,第4期 Liwei An^1,2，Ruixian Yu¹，Yi Han²，Zhaocai Zhou¹（State Key Laboratory of Genetic Engineering Zhongshan Hospital School of Life Sciences Fudan University；Department of Medical Ultrasound Shanghai Tenth People’s Hospital Tongji University School of MedicineShanghai Engineering Research Centre of Ultrasound Diagnosis and Treatment）.Decoding the intercellular communication network during tumorigenesis[J].Cancer Biology & Medicine,2022,第3期 Hanfei Guo， Lei Qian， Jiuwei Cui（Cancer Center，the First Hospital of Jilin University，Changchun 130021，China）.Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome[J].Cancer Biology & Medicine,2022,第3期 Kaiting Wang¹，Xinyao Qiu²，Yan Zhao¹，Hongyang Wang^3,4，Lei Chen⁴（School of Life Sciences Fudan University；Fudan University Shanghai Cancer Center Department of Oncology Shanghai Medical College Fudan University；Institute of Metabolism & Integrative Biology (IMIB) Fudan University；The International Cooperation Laboratory on Signal TransductionEastern Hepatobiliary Surgery Hospital Second Military Medical University）.The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma[J].Cancer Biology & Medicine,2022,第3期 Nahid Arghiani^1,2，Khalid Shah^1,2,3（Center for Stem Cell and Translational Immunotherapy (CSTI) Harvard Medical School Boston MA 02115；Department of Neurosurgery Brigham and Women’s Hospital Harvard Medical School Boston MA 02115；Harvard Stem Cell Institute Harvard University Cambridge MA 02138）.Modulating microRNAs in cancer: next-generation therapies[J].Cancer Biology & Medicine,2022,第3期 Xiaowei Ji^1,2，Jing Wang²，Zhuoying Li^1,2，Qiuming Shen^1,2，Jiayi Tuo^1,2，Jinghao Bi^1,2，Yuting Tan²，Honglan Li²，Yongbing Xiang^1,2（State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology Shanghai Cancer Institute Renji Hospital Shanghai Jiao Tong University School of Medicine；School of Public Health Shanghai Jiao Tong University School of Medicine）.Dietary fat intake and liver cancer risk: A prospective cohort study in Chinese women[J].Cancer Biology & Medicine,2022,第3期 Ming Bai；Meng Wang；Ting Deng；Yuxian Bai²；Kai Zang³；Zhanhui Miao⁴；Wenlin Gai⁵；Liangzhi Xie^5,6,7；Yi Ba（Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy；Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital；Department of Medical Oncology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University；Oncology Department,The First Affiliated Hospital of Xinxiang Medical University；Sinocelltech Ltd.；Beijing Engineering Research Center of Protein and Antibody；Cell Culture Engineering Center,Chinese Academy of Medical Sciences & Peking Union Medical College）.Safety and efficacy of anti-EGFR monoclonal antibody(SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma[J].Cancer Biology & Medicine,2022,第3期 Hua Ye¹，Tianqi Chen²，Zhancheng Zeng²，Bo He³，Qianqian Yang²，Qi Pan²，Yueqin Chen²，Wentao Wang²（Department of Hepatobiliary Sun Yat-sen Memorial Hospital Sun Yat-sen University；Key Laboratory of Gene Engineering of the Ministry of Education School of Life Sciences Sun Yat-sen University；Department of Anesthesiology Sun Yat-sen Memorial Hospital Sun Yat-sen University）.The m6A writers regulated by the IL-6/STAT3 inflammatory pathway facilitate cancer cell stemness in cholangiocarcinoma[J].Cancer Biology & Medicine,2022,第3期 Hui Yang¹，Yinuo Wang¹，Peng Wang¹，Ning Zhang¹，Pengyuan Wang^1,2（Translational Cancer Research Center Peking University First Hospital；Division of General SurgeryPeking University First Hospital）.Tumor organoids for cancer research and personalized medicine[J].Cancer Biology & Medicine,2022,第3期 Yingcheng Wu¹，Tiancheng Zhang¹，Xiaoming Zhang²，Qiang Gao^1,3,4（Department of Liver Surgery and Transplantation Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) Liver Cancer Institute Zhongshan Hospital Fudan University；The Center for MicrobesDevelopment and Health Key Laboratory of Molecular Virology and Immunology Institute Pasteur of Shanghai Chinese Academy of Sciences；Key Laboratory of Medical Epigenetics and Metabolism Institutes of Biomedical Sciences Fudan University；State Key Laboratory of Genetic Engineering Fudan University）.Decoding the complexity of metastasis[J].Cancer Biology & Medicine,2022,第3期 Wei Liu^1,2，Yongping Cui³，Wen Liu⁴，Zhihua Liu⁵，Liyan Xu²，Enmin Li²（College of Science Heilongjiang Institute of Technology；Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology the Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area Shantou University Medical College；Department of Pathology Key Laboratory of Cellular Physiology (Shanxi Medical University) Ministry of Education；Fujian Provincial Key Laboratory of Innovative Drug Target Research School of Pharmaceutical Sciences Xiamen University；State Key Lab of Molecular Oncology National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College）.Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma[J].Cancer Biology & Medicine,2022,第3期 Xixi Li， Xinya Gao， Nu Zhang（Department of Neurosurgery，Sun Yat-sen University，The First Affiliated Hospital of Sun Yat-sen University，Guangzhou 510080，China）.Perspective on novel proteins encoded by circular RNAs in glioblastoma[J].Cancer Biology & Medicine,2022,第3期 Jingyu Ge^1,2，Wenjia Zuo^1,2，Yiyu Chen^1,2，Zhiming Shao^1,2，Keda Yu^1,2（Department of Breast SurgeryFudan University Shanghai Cancer Center；Shanghai Medical CollegeFudan University）.The advance of adjuvant treatment for triple-negative breast cancer[J].Cancer Biology & Medicine,2022,第2期 Yufei Jiang^1,2,3，Huiyun Yuan^2,3，Zhuoying Li^1,2,3，Xiaowei Ji^1,2,3，Qiuming Shen^1,2,3，Jiayi Tuo^1,2,3，Jinghao Bi^1,2,3，Honglan Li^1,2，Yongbing Xiang^1,2,3（State Key Laboratory of Oncogene and Related Genes & Department of EpidemiologyShanghai Cancer InstituteRenji HospitalShanghai Jiao Tong University School of Medicine；Renji HospitalShanghai Jiao Tong University School of Medicine；School of Public HealthShanghai Jiao Tong University School of Medicine）.Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data[J].Cancer Biology & Medicine,2022,第2期 Sha Li^1,2，Jinyi Liu^1,2，Xiangjin Zheng^1,2，Liwen Ren^1,2，Yihui Yang^1,2，Wan Li^1,2，Weiqi Fu^1,2，Jinhua Wang^1,2，Guanhua Du^1,2（The State Key Laboratory of Bioactive Substance and Function of Natural Medicines；Key Laboratory of Drug Target Research and Drug ScreenInstitute of Materia MedicaChinese Academy of Medical Science and Peking Union Medical College）.Tumorigenic bacteria in colorectal cancer: mechanisms and treatments[J].Cancer Biology & Medicine,2022,第2期 Yu Yu¹，Minzhen Tao²，Libin Xu³，Lei Cao⁴，Baoyu Le⁵，Na An⁵，Jilin Dong⁵，Yajie Xu⁵，Baoxing Yang⁵，Wei Li⁵，Bing Liu⁵，Qiong Wu⁶，Yinying Lu⁷，Zhen Xie²，Xiaohua Lian¹（Department of Cell BiologyBasic Medical CollegeArmy Medical University (Third Military Medical University)；MOE Key Laboratory of Bioinformatics and Bioinformatics DivisionCenter for Synthetic and System BiologyDepartment of AutomationBeijing National Research Center for Information Science and TechnologyTsinghua University；National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical College；Department of Thoracic SurgeryPeking Union Medical College HospitalChinese Academy of Medical Sciences；Beijing Syngentech Co.Ltd；School of Life SciencesTsinghua University；The Comprehensive Liver Cancer CenterThe 5th Medical Center of PLA General Hospital）.Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells[J].Cancer Biology & Medicine,2022,第2期 Fenfen Fu¹，Dongjie Zhang¹，Li Hu²，Senthil Sundaram³，Dingge Ying³，Ying Zhang⁴，Shuna Fu⁴，Juan Zhang²，Lu Yao²，Ye Xu²，Yuntao Xie^1,2（Department of Breast Surgery, Peking University International Hospital；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Familial & Hereditary Cancer Center, Peking University Cancer Hospital & Institute；Prenetics Limited；Beijing CircleDNA Gene Technology Co., Ltd.）.Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women[J].Cancer Biology & Medicine,2022,第2期 Qian Hao^1,2，Xiang Zhou^1,2,3,4（Fudan University Shanghai Cancer Center and Institutes of Biomedical SciencesFudan University；Department of OncologyShanghai Medical CollegeFudan University；Key Laboratory of Breast Cancer in ShanghaiFudan University Shanghai Cancer CenterFudan University；Shanghai Key Laboratory of Medical EpigeneticsInternational Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology)Institutes of Biomedical SciencesFudan University）.The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy[J].Cancer Biology & Medicine,2022,第2期 Xinyi Zhou¹，Qian Xiao¹，Dongliang Fu¹，Haochen Zhang²，Yang Tang¹，Jinjie He¹，Yeting Hu¹，Xiangxing Kong¹，Fei Teng³，Xiangrui Liu⁴，Ying Yuan²，Kefeng Ding^1,5（Department of Colorectal Surgery and Oncology；Department of Medical OncologyKey Laboratory of Cancer Prevention and InterventionMinistry of Educationthe Second Affiliated Hospital of Zhejiang University School of Medicine；Hangzhou Oncocare Co Ltd；Department of PharmacologyZhejiang University School of Medicine；Cancer CenterZhejiang University）.Efficacy of rigosertib,a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer[J].Cancer Biology & Medicine,2022,第2期 Lin Qian^1,2，Fan Zhang^1,2，Miao Yin^1,2，Qunying Lei^1,2,3,4（Fudan University Shanghai Cancer Center & Institutes of Biomedical SciencesCancer InstitutesKey Laboratory of Breast Cancer in ShanghaiShanghai Key Laboratory of Radiation OncologyShanghai Key Laboratory of Medical EpigeneticsShanghai Medical CollegeFudan University；Department of OncologyShanghai Medical CollegeFudan University；State Key Laboratory of Medical NeurobiologyFudan University；Lead Contact）.Cancer metabolism and dietary interventions[J].Cancer Biology & Medicine,2022,第2期 Poorni M.Manohar^1,2，Nancy E.Davidson^1,2（University of Washington/Seattle Cancer Care AllianceSeattle 98109WA；Fred Hutchinson Cancer Research CenterSeattle 98109WA）.Updates in endocrine therapy for metastatic breast cancer[J].Cancer Biology & Medicine,2022,第2期 Yuchen Guo，Yangyang Zhou，Wenxin Qin（State Key Laboratory of Oncogenes and Related GenesShanghai Cancer InstituteRenji HospitalShanghai Jiao Tong University School of Medicine）.A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer[J].Cancer Biology & Medicine,2022,第2期 Xiaodong Zhang，Chunyu Hou，Guang Yang（Department of Gastrointestinal Cancer Biology，Liver Cancer Center，Tianjin Medical University Cancer Institute&Hospital，National Clinical Research Center for Cancer，Key Laboratory of Cancer Prevention and Therapy，Tianjin，Tianjin's Clinical Research Center for Cancer，Tianjin 300060，China）.Highlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumors[J].Cancer Biology & Medicine,2022,第2期 Mengyuan Yang，Yingxin Zhao，Yuwei Ding，Juan Wang，Yinuo Tan，Dong Xu，Ying Yuan（Department of Medical OncologyKey Laboratory of Cancer Prevention and InterventionMinistry of EducationThe Second Affiliated HospitalZhejiang University School of Medicine；Cancer InstituteKey Laboratory of Cancer Prevention and InterventionMinistry of EducationThe Second Affiliated HospitalZhejiang University School of Medicine；Department of Colorectal Surgery and OncologyKey Laboratory of Cancer Prevention and InterventionMinistry of EducationThe Second Affiliated HospitalZhejiang University School of Medicine）.Erratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposis[J].Cancer Biology & Medicine,2022,第2期 Mengyuan Yang，Yingxin Zhao，Yuwei Ding，Juan Wang，Yinuo Tan，Dong Xu，Ying Yuan（Key Laboratory of Cancer Prevention and Intervention，Ministry of Education，The Second Affiliated Hospital，Zhejiang University School of Medicine，Hangzhou；The Second Affiliated Hospital，Zhejiang University School of Medicine，Hangzhou 310009）.Erratum to A truncated protein product of the germline variant of the DU0X2 gene leads to adenomatous polyposis[J].癌症生物学与医学(英文版),2022,第2期 Yan Zeng¹，Yutian Zou¹，Guanfeng Gao¹，Shaoquan Zheng¹，Song Wu¹，Xiaoming Xie¹，Hailin Tang¹（Sun Yat-sen University Cancer Center；State Key Laboratory of Oncology in South China；Collaborative Innovation Center for Cancer Medicine）.The biogenesis,function and clinical significance of circular RNAs in breast cancer[J].Cancer Biology & Medicine,2022,第1期 Mingyan He^1,2，Jing Hu³，Tingting Fang²，Wenqing Tang²，Bei Lv²，Biwei Yang²，Jinglin Xia^2,4（Department of Gastroenterologythe First Affiliated Hospital of Nanchang University；Liver Cancer InstituteZhongshan HospitalFudan University；Department of CardiologyJiangxi Provincial People’s Hospital Affiliated to Nanchang University；Department of OncologyThe First Affiliated Hospital of Wenzhou Medical University）.Protein convertase subtilisin/Kexin type 9 inhibits hepatocellular carcinoma growth by interacting with GSTP1 and suppressing the JNK signaling pathway[J].Cancer Biology & Medicine,2022,第1期首页上一页 2 3 4 5 下一页尾页共有5页，转到页

期刊文章列表